240
Participants
Start Date
May 20, 2022
Primary Completion Date
May 20, 2024
Study Completion Date
May 20, 2026
Edoxaban
"Patients in the Edoxaban group take Edoxaban 60mg once daily. If any of the following conditions are present, take 30mg once daily.~* CrCl 15-50mL/min~* Body weight ≤ 60kg~* Concomitant use of P-glycoprotein inhibitor (Dronearone, Ciclosporine, Erythromycin or Ketoconazole)"
Warfarin
Patients in the Warfarin group take Warfarin 2-10mg once daily, dose adjusted with the target INR 2-3. In the elderly or frail patients, a lower dose administration is allowed at the discretion of the investigator.
RECRUITING
Uijeongbu St. Mary's Hospital, Uijeongbu-si
RECRUITING
Bucheon St. Mary's hospital, Bucheon-si
RECRUITING
St. Vincent hospital, Suwon
RECRUITING
Incheon St. Mary's hospital, Incheon
RECRUITING
Daejeon St. Mary's hospital, Daejeon
RECRUITING
Seoul St. Mary's Hospital, Seoul
RECRUITING
Yeouido St. Mary's hospital, Yeongdeungpo-gu
Daiichi Sankyo Korea Co., Ltd.
INDUSTRY
Sung-Hwan Kim
OTHER